Skip to main content
SpringerLink
Log in

Role of Laboratory in Hematopoietic Stem Cell Transplantation

  • Chapter
  • First Online:
Hematopathology

  • 1240 Accesses

Abstract

Hematopoietic stem cell transplantation (HSCT) is considered as the standard of care for numerous hematological malignancies. A successful HSCT requires the support of a good clinical laboratory which performs various routine clinical tests as well as transplantation specific investigations. While a transplantation-specific laboratory should be well equipped and have the infrastructure for performing investigations pertaining to tissue typing, CD34 enumeration by flow cytometry, assessment of graft viability/rejection, evaluation of minimal residual disease, and measurement of immunosuppressive drugs; the importance of the routine clinical laboratory tests like biochemical, hematological, serological, urinary, and microbiological examinations too cannot be undermined in a transplant setup. The clinical laboratory monitoring is important at each step and contributes to an early diagnosis, monitoring, and thereby enhancing prevention and treatment of the complications or adverse events. It is essential to provide information regarding engraftment, chimerism, diagnosing infections, veno-occlusive disease, therapy-related toxicities, graft versus host disease, and thrombotic microangiopathy which are the major causes of mortality and morbidity in HSCT. In this chapter, the importance of a laboratory in different facets of HSCT will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kanda Y, Kanda J, Atsuta Y, et al. Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation. Biol Blood Marrow Transplant. 2014;20:526–35.

    Article  CAS  Google Scholar 

  2. Krausa P, Browning M. Detection of HLA gene polymorphism. In: Browning M, McMichael A, editors. HLA and MHC: genes, molecules and function. Oxford: BIOS Scientific; 1996. p. 113–37.

    Google Scholar 

  3. Piancatelli D. Human leukocyte antigen-A, -B, and -Cw polymorphism in a Berber population from North Morocco using sequence-based typing. Tissue Antigens. 2004;26:78–87.

    Google Scholar 

  4. Ferrer A, Fernandez ME, Nazabal M. Biotechnol Aplicada. 2005;22:91–101.

    CAS  Google Scholar 

  5. Erlich HA, Opelz G, Hansen J. Immunity. 2001;14:347–56.

    Article  CAS  Google Scholar 

  6. Dunn PP. Novel approaches and technologies in molecular HLA typing. Methods Mol Biol. 2015;1310:213–0300.

    Article  Google Scholar 

  7. Nunes E, Heslop H, Fernandez-Vina M, Taves C, Wagenknecht DR, Eisenbrey AB, et al. Definitions of histocompatibility typing terms. Blood. 2011;118:e180–3.

    Article  CAS  Google Scholar 

  8. Olerup O, Zetterquist H. HLA-DRB1*01 subtyping by allele-specific PCR amplification: a sensitive, specific and rapid technique. Tissue Antigens. 1991;37:197–204.

    Article  CAS  Google Scholar 

  9. Testi M, Andreani M. Luminex-based methods in high-resolution HLA typing. Methods Mol Biol. 2015;1310:231–45.

    Article  Google Scholar 

  10. Zhang GL, Keskin DB, Lin HN, Lin HH, De Luca DS, Leppanen S, et al. Human leukocyte antigen typing using a knowledge base coupled with a high-throughput oligonucleotide probe array analysis. Front Immunol. 2014;5:597.

    PubMed  PubMed Central  Google Scholar 

  11. Erlich H. HLA DNA typing: past, present, and future. Tissue Antigens. 2012;80:1–11.

    Article  CAS  Google Scholar 

  12. Hourmant M, Cesbron-Gautier A, Terasaki PI, Mizutani K, Moreau A, Meurette A, et al. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol. 2005;16:2804–12.

    Article  CAS  Google Scholar 

  13. Ottinger HD, Rebmann V, Pfeiffer KA, Beelen DW, Kremens B, Runde V, et al. Positive serum crossmatch as predictor for graft failure in HLA mismatched allogeneic blood stem cell transplantation. Transplantation. 2002;73:1280–5.

    Article  Google Scholar 

  14. Allan DS, Keeney M, Howson-Jan K, et al. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:967–72.

    Article  CAS  Google Scholar 

  15. Bittencourt H, Rocha V, Chevret S, Socié G, Espérou H, Devergie A, et al. Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;99:2726–33.

    Article  CAS  Google Scholar 

  16. Sutherland RD, Michael Keeney M, Gratama JW. Enumeration of CD34+ hematopoietic stem and progenitor cells. Curr Protoc Cytom. 2003;25:6.4.1–6.4.23.

    Article  Google Scholar 

  17. Siena S, Bregni M, Belli N. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood. 1991;77:400–9.

    CAS  PubMed  Google Scholar 

  18. Sutherland DR, Anderson L, Keeney M. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. J Hematother. 1996;5:213–36.

    Article  CAS  Google Scholar 

  19. Sutherland DR, Nayyar R, Acton E, Giftakis A, Dean S, Mosiman VL. Comparison of two single-platform ISHAGEbased CD34 enumeration protocols on BD FACSCalibur and FACSCantoflow cytometers. Cytotherapy. 2009;11:595–605.

    Article  CAS  Google Scholar 

  20. Aird W, Labopin M, Gorin NC, Antin JH. Long-term cryopreservation of human stem cells. Bone Marrow Transplant. 1992;9:487–90.

    CAS  PubMed  Google Scholar 

  21. Gonçalves TL, Benvegnú DM, Bonfanti G. Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation. Oxidative Med Cell Longev. 2009;2:82–7.

    Article  Google Scholar 

  22. Morkis IV, Farias MG, Rigoni LD, Scotti L, Gregianin LJ, Daudt LE, et al. Assessment of immature platelet fraction and immature reticulocyte fraction as predictors of engraftment after hematopoietic stem cell transplantation. Int J Lab Hematol. 2015;37:259–64.

    Article  CAS  Google Scholar 

  23. Rose HJ. A handbook of Greek mythology. London: Routledge; 1989.

    Google Scholar 

  24. McCann SR, Lawler M. Mixed chimerism: detection and significance following BMT. Bone Marrow Transplant. 1993;11:91–4.

    CAS  PubMed  Google Scholar 

  25. Khan F, Agarwal A, Agrawal S. Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme. Bone Marrow Transplant. 2004;34:1–12.

    Article  CAS  Google Scholar 

  26. Ghaffari SH, Chahardouli B, Gavamzadeh A, Alimoghaddam K. Evaluation of hematopoietic Chimerism following allogeneic peripheral blood stem cell transplantation with Amelogenin marker. Arch Iranian Med. 2008;11:35–41.

    CAS  Google Scholar 

  27. Lion T. Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection. Leukemia. 2003;17:252–4.

    Article  CAS  Google Scholar 

  28. Brunstein CG, Hirsch BA, Miller JS, et al. Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenousleukemia: extended remission preceding eventual relapse. Bone Marrow Transplant. 2000;26:1173–7.

    Article  CAS  Google Scholar 

  29. van der Velden VH, Hochhaus A, Cazzaniga G, et al. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia. 2003;17:1013–34.

    Article  Google Scholar 

  30. Maschmeyer G, Ljungman P. Infections in hematopoietic stem cell transplant recipients. In: Safdar A, editor. Principles and practice of cancer infectious diseases, current clinical oncology. Berlin: Springer Science+Business Media, LLC; 2011. https://doi.org/10.1007/978-1-60761-644-3_2.

    Chapter  Google Scholar 

  31. Walter E, Bowden RA. Infection in the bone marrow transplant recipient. Infect Dis Clin N Am. 1995;9:823–47.

    CAS  Google Scholar 

  32. Nichols WG, Corey L, Gooley T, et al. High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. J Infect Dis. 2002;185:273–82.

    Article  Google Scholar 

  33. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, John R, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143–238.

    Article  CAS  Google Scholar 

  34. Akan H, Antia VP, Kouba M, Sinkó J, Tănase AD, Vrhovac R, et al. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects. J Antimicrob Chemother. 2013;68:5–16.

    Article  Google Scholar 

  35. Richardson M, Ellis M. Clinical and laboratory diagnosis. Hosp Med. 2000;61:610–4.

    Article  CAS  Google Scholar 

  36. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis. 2006;42:1417–27.

    Article  CAS  Google Scholar 

  37. Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis. 2004;39:199–205.

    Article  CAS  Google Scholar 

  38. Pickering JW, Sant HW, Bowles CAP, Roberts WL, Woods GL. Evaluation of a (17→3)-b-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol. 2005;43:5957–62.

    Article  CAS  Google Scholar 

  39. Glucksberg HR, storb R, Fefer A, Buckner cD, Neiman pE, clift RA, Lerner KG, Thomas ED. Clinical manifestations of graft-versus-host disease in human recipients of marrow from Hl-A-matched sibling donors. Transplantation. 1974;18:295–304.

    Article  CAS  Google Scholar 

  40. Wakui M, Okamoto S, Ishida A, et al. Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation. Bone Marrow Transplant. 1999;23:573.

    Article  CAS  Google Scholar 

  41. Sale GE, Shulman HM, McDonald GB, Thomas ED. Gastrointestinal graft-versus-host disease in man. A clinicopathologic study of the rectal biopsy. Am J Surg Pathol. 1979;3:291–9.

    Article  CAS  Google Scholar 

  42. Bone Marrow Transplantation. Cambridge, MA: Blackwell; 1994.

    Google Scholar 

  43. Shulman HM, Cardona DM, Greenson JK et al. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015;21(4):589–603.

    Article  Google Scholar 

  44. Esteban JM, Somlo G. Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature. Mod Pathol. 1995;8:59–64.

    CAS  PubMed  Google Scholar 

  45. O’Shaughnessy EM, Shea YM, Witebsky FG. Laboratory diagnosis of invasive mycoses. Infect Dis Clin N Am. 2003;17:135–58.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Dinesh Chandra & Ruchi Gupta

Authors
  1. Dinesh Chandra
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ruchi Gupta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dinesh Chandra .

Editor information

Editors and Affiliations

  1. Department of Hematology, All India Institute of Medical Sciences, New Delhi, India

    Renu Saxena

  2. Department of Hematology, All India Institute of Medical Sciences, New Delhi, India

    Hara Prasad Pati

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chandra, D., Gupta, R. (2019). Role of Laboratory in Hematopoietic Stem Cell Transplantation. In: Saxena, R., Pati, H. (eds) Hematopathology. Springer, Singapore. https://doi.org/10.1007/978-981-13-7713-6_24

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-7713-6_24

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-7712-9

  • Online ISBN: 978-981-13-7713-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation